SEARCH

MENU

Current Edition

AstraZeneca wagers $200M on Ionis’ next chance at a rare disease drug

AstraZeneca is betting that Ionis’ second drug for transthyretin amyloidosis, or ATTR, will stand out where its first one couldn’t. Ionis developed Tegsedi for years …

10 December 2021 AstraZeneca ATTR

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte LTD